AJP - Regulatory, Integrative and Comparative Physiology, Vol 266, Issue 5 1437-R1442, Copyright © 1994 by American Physiological Society

ARTICLES

Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR

A. Numabe, K. Komatsu and E. D. Frohlich
Hypertension Research Laboratories, Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121.

To investigate the prolonged effects of angiotensin-converting enzyme (ACE) inhibition and alpha 1-adrenoceptor blockade on intrarenal hemodynamics, whole kidney and renal micropuncture studies were performed in male 21-wk-old Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats treated for 3 wk with quinapril (3 mg/kg), terazosin (1 mg/kg), or in their combination (quinapril 1.5 mg/kg and terazosin 0.5 mg/kg). In WKY, only quinapril significantly reduced mean arterial pressure (MAP) associated with reduced afferent arteriolar resistance; there were no other significant changes. In contrast, all treatments similarly decreased MAP in SHR. Quinapril increased renal plasma flow and decreased filtration fraction. With respect to intrarenal hemodynamics, quinapril increased single-nephron plasma flow and reduced glomerular capillary pressure (from 53.1 to 47.8 mmHg; P < 0.01), associated with reduced afferent (from 4.80 to 3.17 10(10)dyn.s.cm-5; P < 0.01) and efferent (from 1.70 to 1.17 10(10)dyn.s.cm-5; P < 0.01) arteriolar resistances, and increased ultrafiltration coefficient (from 0.037 to 0.052 nl.s-1.mmHg-1; P < 0.05). Terazosin only reduced arteriolar resistance. The combined treatment attenuated either agent's independent effects on glomerular hemodynamics. These data demonstrate that prolonged ACE and adrenergic inhibition therapy alone or in combination produce different effects than when given by vein, suggesting that prolonged renopressor system inhibition may be more effective than adrenergic in SHR.

This article has been cited by other articles:

				J. F. Reckelhoff, H. Zhang, and K. Srivastava Gender Differences in Development of Hypertension in Spontaneously Hypertensive Rats : Role of the Renin-Angiotensin System Hypertension, January 1, 2000; 35(1): 480 - 483. [Abstract] [Full Text] [PDF]

				F. I. Kvam, J. Ofstad, and B. M. Iversen Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR Am J Physiol Renal Physiol, October 1, 1998; 275(4): F576 - F584. [Abstract] [Full Text] [PDF]

				A. Francischetti, H. Ono, and E. D. Frohlich Renoprotective Effects of Felodipine and/or Enalapril in Spontaneously Hypertensive Rats With and Without L-NAME Hypertension, March 1, 1998; 31(3): 795 - 801. [Abstract] [Full Text] [PDF]

				R. Largo, D. Gomez-Garre, X. H. Liu, J. Alonso, J. Blanco, J. J. Plaza, and J. Egido Endothelin-1 Upregulation in the Kidney of Uninephrectomized Spontaneously Hypertensive Rats and Its Modification by the Angiotensin-Converting Enzyme Inhibitor Quinapril Hypertension, May 1, 1997; 29(5): 1178 - 1185. [Abstract] [Full Text]

				K. Skov, J. Fenger-Gron, and M. J. Mulvany Effects of an Angiotensin-Converting Enzyme Inhibitor, a Calcium Antagonist, and an Endothelin Receptor Antagonist on Renal Afferent Arteriolar Structure Hypertension, September 1, 1996; 28(3): 464 - 471. [Abstract] [Full Text]

				H. Ono, Y. Ono, and E. D. Frohlich ACE Inhibition Prevents and Reverses L-NAMEExacerbated Nephrosclerosis in Spontaneously Hypertensive Rats Hypertension, February 1, 1996; 27(2): 176 - 183. [Abstract] [Full Text]

				H. Ono, Y. Ono, and E. D. Frohlich Nitric Oxide Synthase Inhibition in Spontaneously Hypertensive Rats : Systemic, Renal, and Glomerular Hemodynamics Hypertension, August 1, 1995; 26(2): 249 - 255. [Abstract] [Full Text]

				K. Komatsu, E. D. Frohlich, H. Ono, Y. Ono, A. Numabe, and G. W. Willis Glomerular Dynamics and Morphology of Aged Spontaneously Hypertensive Rats : Effects of Angiotensin-Converting Enzyme Inhibition Hypertension, February 1, 1995; 25(2): 207 - 213. [Abstract] [Full Text]